Rallybio Corp Cash Flow-to-Debt Ratio
Rallybio Corp cash flow-to-debt ratio. Rallybio Corp (RLYB) has a Cash Flow-to-Debt Ratio of 12.77x as of June 2026, meaning its operating cash flow of $45.55 Million could theoretically repay 13% of its total liabilities ($3.57 Million) in one year. Check RLYB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Rallybio Corp (2019–2025)
Cash flow-to-debt ratio of Rallybio Corp from 2019 to 2025. Historical debt coverage capacity for Rallybio Corp across 7 annual periods. Check RLYB cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Rallybio Corp Cash Flow-to-Debt Ratio by Year (2019–2025)
Rallybio Corp cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Rallybio Corp. For the full cash flow conversion analysis, see cash efficiency ratio of Rallybio Corp.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.93x | $-29.81 Million | $4.30 Million | ▲ +9.3% |
| 2024 | -7.64x | $-49.28 Million | $6.45 Million | ▼ -19.6% |
| 2023 | -6.39x | $-60.27 Million | $9.44 Million | ▼ -24.0% |
| 2022 | -5.15x | $-57.28 Million | $11.12 Million | ▲ +25.5% |
| 2021 | -6.92x | $-45.53 Million | $6.58 Million | ▼ -83.8% |
| 2020 | -3.76x | $-22.04 Million | $5.86 Million | ▼ -18.9% |
| 2019 | -3.17x | $-15.03 Million | $4.75 Million | — |